Evidence map›Paper›PMID 42223532›Full record

ReviewJournal of computer-aided molecular design2026

Reproducibility, validation, and failure modes across classical and AI-driven molecular docking.

Katiana Simões Kittelson, Allana C F Martins, Raquel Possemozer Santos, Gizele Celante, Roberto da Silva Gomes

Abstract readReview
In one paragraph

Review in Journal of computer-aided molecular design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Katiana Simões Kittelson *Department of Pharmaceutical Sciences, College of Health and Human Sciences, North Dakota State University, Fargo, ND, USA.ORCID 0000-0002-8082-4469
Allana C F Martins *Department of Pharmaceutical Sciences, College of Health and Human Sciences, North Dakota State University, Fargo, ND, USA.ORCID 0000-0001-5647-2187
Raquel Possemozer SantosDepartment of Pharmaceutical Sciences, College of Health and Human Sciences, North Dakota State University, Fargo, ND, USA.ORCID 0009-0005-1807-175X
Gizele CelanteDepartment of Pharmaceutical Sciences, College of Health and Human Sciences, North Dakota State University, Fargo, ND, USA. gizele.celante@ndsu.edu.ORCID 0000-0003-2654-4332
Roberto da Silva GomesDepartment of Pharmaceutical Sciences, College of Health and Human Sciences, North Dakota State University, Fargo, ND, USA. roberto.gomes@ndsu.edu.ORCID 0000-0002-8075-9716

Funding

NIGMS NIH HHS 3P20GM109024
6 · The paper itself

Abstract

Molecular docking is indispensable across computer‑aided discovery. However, its conclusions often hinge more on modeling choices than on software brand or nominal score. In this review, we argue that docking should be treated explicitly as conditional modeling whose interpretability depends on structural provenance, ligand‑state definition, search‑space design, and validation under deployment‑relevant conditions. This framework is intended as a practical reference for evaluating docking rigor across both academic and applied workflows. We highlight recurrent failure modes, cross‑target score comparisons under non‑comparable states, over‑read scores as affinities, under‑modeled solvation/flexibility, and uncritical use of predicted structures, and show how AI both exacerbates and mitigates these risks. We then propose best practices for modern validation (self‑docking as necessary but insufficient; cross‑docking, decoys, apo/predicted structures, and out‑of‑distribution tests as essential complements) and offer a concise FAIR reporting checklist enabling reuse and audit. Looking forward, we contend that the most valuable advances are those that improve deployment‑relevant reliability, pose plausibility, enrich screening, and enhance robustness across receptor uncertainty, rather than tool novelty alone. This review reframes docking success from "obtaining a pose and a score" to earning confidence through transparent workflows and evaluation aligned with real use. In this context, the term "AI-driven" does not imply replacing physics-based docking, but rather expanding the workflow landscape in which classical and machine learning approaches coexist. This review, therefore, treats docking as a unified decision framework spanning both paradigms, with emphasis on how validation, generalization, and reproducibility requirements evolve in AI-assisted workflows.

Indexed as

Artificial IntelligenceMolecular Docking SimulationProteinsComputer-Aided DesignHumansLigandsProtein BindingReproducibility of ResultsSoftwareLigandsProteinsComputer-aided drug designDocking validationMachine learningMolecular dockingProtein-ligand interactionsReproducibility benchmarkingScoring functionsVirtual screening

Identifiers

PMID42223532
PMCPMC13226364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.